Maciej Markiewski
Company: Texas Tech University Health Sciences Center
Job title: Professor
Seminars:
Panel Discussion: Novel Modalities & Next Generation of Complement Inhibitors 4:00 pm
Where is the next step for complement inhibitors? Examine the past, present, and future, of complement inhibitors for autoimmune conditions and they may fit alongside existing therapiesRead more
day: End of Conference Day Two
Complement in Oncology 9:30 am
Rationale for targeting complement in cancer therapy Preclinical and clinical data supporting complement inhibition in oncology Challenges and opportunities in developing complement-targeted therapies Combination therapies with other cancer treatmentsRead more
day: Conference Day Two
Panel: The Past, Present & Future of Complement in Oncology 10:00 am
Where to target for oncology indications? Discussing complement dependent mechanisms in angiogenesis How can newly discovered complement functions be targeted for therapy?Read more
day: Conference Day Two
Panel Discussion: Dysregulation Insights: An Overview of the Complement System in Health & Human Disease 8:30 am
Unravelling the 3 complement pathways and potential intervention points Understanding core processes in healthy inflammatory response in comparison to pathophysiology of autoimmune conditions Discussing the optimal modalities for delivering complement mediated drugs: small molecules, antibodies, and gene therapiesRead more
day: Conference Day One
Navigating Clinical Trials: Overcoming Challenges in Complement Drug Development for Breakthrough Success 3:30 pm
Delving into the strategic expansion of indications for complement inhibitors beyond their initial targets. Explore the processes and considerations involved in identifying new therapeutic areas, conducting late-stage translational research, and managing clinical development to bring these therapies from rare disease to indications like dry AMD. Design trials that include both traditional and innovative endpoints, such…Read more
day: Pre-Conference Workshop Day